Dose Exploration Study OF JWCAR129, BCMA-Targeted CART for RRMM

Status Recruiting

Clinical Trial Summary

This is an open-label, Phase 1 dose exploration study to evaluate the safety and tolerability and to determine recommended Phase 2 dose(s) of JWCAR129, a CAR T-cell product that targets B-cell maturation antigen (BCMA), in adult subjects with relapsed and/or refractory multiple myeloma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Safety and Efficacy

Clinical Trial Details

NCT number	NCT04677452
Study type	Interventional
Source	The First Affiliated Hospital of Soochow University
Contact
Status	Recruiting
Phase	Phase 1
Start date	December 2020
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04994210` - Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL	Phase 2
Terminated	`NCT05247957` - NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia	N/A
Completed	`NCT04621123` - Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients	Phase 2
Recruiting	`NCT05140616` - Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD	Phase 1/Phase 2
Recruiting	`NCT05349552` - Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
Completed	`NCT03820596` - Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL	Phase 1/Phase 2
Not yet recruiting	`NCT05556889` - Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block	N/A
Recruiting	`NCT04446806` - Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia	Phase 4
Not yet recruiting	`NCT06244537` - Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer	N/A
Recruiting	`NCT03455972` - Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT	Phase 1/Phase 2
Completed	`NCT04785170` - Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals	N/A
Completed	`NCT01305044` - The HEALS Project - Health Education and Active Living for Surviving Seniors	Phase 2
Active, not recruiting	`NCT04646590` - A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19	Phase 3
Recruiting	`NCT05021276` - Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD	Phase 4
Not yet recruiting	`NCT05008666` - Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH	Phase 2
Recruiting	`NCT06066840` - Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement	Phase 4
Active, not recruiting	`NCT04852068` - A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)	Phase 3